SHG Microscopy for Trace Crystallinity Detection in Amorphous Dispersions
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting crystallinity in amorphous pharmaceutical formulations, such as X-ray powder diffraction and Raman spectroscopy, face challenges with high detection limits, often struggling to distinguish crystallinity at low levels due to background noise from the amorphous fraction, which is critical for ensuring drug bioavailability and compliance with stringent regulations.
Innovation Solution
The method employs second harmonic generation (SHG) microscopy to rapidly identify regions of interest, guiding targeted Raman spectroscopy and X-ray diffraction (XRD) measurements, thereby reducing background noise and enhancing detection limits by focusing analysis on specific crystalline areas within the sample.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional methods (PXRD, DSC, Raman spectroscopy) are used to detect crystallinity, then measurement coverage is comprehensive, but detection limit is poor due to background noise from amorphous fraction
Solution Approach 1:
The method segments the analysis process into two distinct stages: first using SHG microscopy to identify and locate crystalline regions of interest, then applying conventional techniques (Raman spectroscopy, PXRD) only to those specific regions. This segmentation isolates the crystalline signal from the amorphous background, enabling detection limits as low as 0.1% crystallinity while eliminating the harmful background noise that plagues conventional bulk analysis methods.
Solution Approach 2:
The invention applies local quality by transitioning from bulk analysis to localized analysis. SHG microscopy provides spatial mapping of crystalline regions, allowing subsequent Raman and PXRD measurements to be focused exclusively on crystalline domains. This local approach ensures that the measurement quality is optimized for crystalline detection without contamination from surrounding amorphous material, achieving superior detection limits.
2Measurement precision
If conventional methods are used for crystallinity detection, then analysis is straightforward, but measurement time is excessive for low-level crystallinity
Solution Approach 1:
The method performs preliminary action by using SHG microscopy to pre-identify and map all crystalline regions within the sample before applying time-consuming conventional analysis techniques. This preliminary mapping step allows subsequent Raman and PXRD measurements to be rapidly acquired from pre-located regions of interest, reducing total measurement time while maintaining high crystallinity quantification accuracy even at low levels (0.1% detection limit).
Solution Approach 2:
The invention implements skipping by bypassing the need for extensive bulk scanning and analysis. Once crystalline regions are identified by SHG microscopy, the method rushes through the conventional analysis steps (Raman, PXRD) focused only on those specific regions, eliminating wasted time analyzing amorphous areas. This approach achieves rapid stability testing capability with high precision crystallinity measurement.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach significantly lowers the detection limits for crystallinity, allowing for more accurate quantification and reducing the timeframe for stability testing, as demonstrated by improved sensitivity and specificity in analyzing the amorphous nanosuspension ABRAXANE®, enabling better prediction of long-term formulation success and compliance with regulatory standards.
Implementation Method 1
second harmonic generation (SHG) microscopy to rapidly identify regions of interest
Implementation Method 2
confocal Raman spectroscopy
Implementation Method 3
X-ray diffraction (XRD) measurements
Data Source
AI summary
A method for quantifying crystallinity within a sample using second harmonic generation microscopy is described herein. In one aspect, a method for reducing the timeframe for accelerated stability testing of amorphous solid dispersions of active pharmaceutical ingredients though identifying regions of interest to quantify crystallinity and composition is presented herein.